| Literature DB >> 36072479 |
Lin-Man Weng1, Rui Wang1, Qi-Hao Yang1, Tian-Tian Chang1, Cheng-Cheng Wu1, Wen-Long Li2, Shu-Hao Du1, Yu-Chen Wang1, Xue-Qiang Wang1,3,4.
Abstract
Background: Increased social distance is one of the manifestations of social impairment. Chronic low back pain (CLBP) is one of factors associated with increased social distance and social withdrawal. Exercise therapy is an effective means to social impairment. However, whether exercise could reduce social distance in patients with CLBP remains unknown. This study aimed to investigate the effect of exercise on social distance in middle-aged and elderly patients with CLBP.Entities:
Keywords: chronic low back pain; exercise therapy; personal space; social distance; stop-distance
Year: 2022 PMID: 36072479 PMCID: PMC9441739 DOI: 10.3389/fnagi.2022.976164
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.702
FIGURE 1Social distance task. (A) The subject (black) is approached by the experimenter (gray) of the same gender. (B) The subject (black) is approached by the experimenter (gray) of the opposite gender. (C) The subject (black) walks toward the experimenter (gray) of the same gender. (D) The subject (black) walks toward the experimenter (gray) of the opposite gender. CD1, The comfortable distance when the subject is approached by the experimenter of the same gender; CD2, The comfortable distance when the subject is approached by the experimenter of the opposite gender; CD3, The comfortable distance when the subject walks toward the experimenter of the same gender; CD4, The comfortable distance when the subject walks toward the experimenter of the opposite gender; UD1, The uncomfortable distance when the subject is approached by the experimenter of the same gender; UD2, The uncomfortable distance when the subject is approached by the experimenter of the opposite gender; UD3, The uncomfortable distance when the subject walks toward the experimenter of the same gender; UD4, The uncomfortable distance when the subject walks toward the experimenter of the opposite gender.
Baseline demographic and clinical characteristics.
| Group, mean ( |
| |||
|
| ||||
| Overall ( | Moderate ( | Mild ( | ||
| Male, | 9 (31.03%) | 4 (30.77%) | 5 (31.25%) | 0.978 |
| Age, years | 65.90 (4.97) | 67.31 (4.35) | 64.75 (5.29) | 0.186 |
| Height, cm | 161.63 (7.62) | 163.12 (7.91) | 160.43 (7.42) | 0.353 |
| Weight, kg | 64.62 (11.43) | 64.02 (7.32) | 65.12 (14.15) | 0.801 |
| BMI (kg/m2) | 24.62 (3.18) | 24.03 (1.86) | 25.10 (3.94) | 0.380 |
| Smoking, | 4 (13.79%) | 1 (7.69%) | 3 (18.75%) | 0.390 |
| Drinking, | 3 (10.34%) | 1 (7.69%) | 2 (12.50%) | 0.672 |
| Education, | 0.214 | |||
| Primary school or below | 1 (3.45%) | / | 1 (6.25%) | NA |
| Junior high school | 10 (34.48%) | 7 (53.85%) | 3 (18.75%) | NA |
| Senior high school | 14 (48.28%) | 5 (38.46%) | 9 (56.25%) | NA |
| College or above | 4 (13.79%) | 1 (7.69%) | 3 (18.75%) | NA |
| Course of CLBP, years | 11.88 (11.14) | 12.73 (13.29) | 11.20 (9.45) | 0.982 |
| Types of pain | 0.422 | |||
| Continuous | 3 (10.34%) | 2 (15.38%) | 1 (6.25%) | NA |
| Intermittent | 26 (89.66%) | 13 (84.62%) | 15 (93.75%) | NA |
| Nature of pain | 0.352 | |||
| Aching pain | 14 (48.28%) | 4 (30.77%) | 10 (65.50%) | NA |
| Bursting pain | 2 (6.90%) | 2 (15.38%) | / | NA |
| Prickling pain | 2 (6.90%) | 1 (7.69%) | 1 (6.25%) | NA |
| Radiant pain | 2 (6.90%) | 1 (7.69%) | 1 (6.25%) | NA |
| Mixed pain | 9 (31.03%) | 5 (38.46%) | 4 (25.00%) | NA |
| SAD | 7.38 (5.18) | 6.38 (4.61) | 8.19 (5.61) | 0.361 |
| IPAQ | NA | |||
| Total physical activity per week (MET-min/w) | 4415.10 (2796.05) | 4120.39 (2991.87) | 4654.54 (2701.10) | 0.599 |
| Physical activity level | 0.730 | |||
| Low | / | / | / | NA |
| Medium | 8 (27.59%) | 4 (30.77%) | 4 (25.00%) | NA |
| High | 21 (72.41%) | 9 (69.23%) | 12 (75.00%) | NA |
BMI, body mass index; CLBP, chronic low back pain; SAD, Social Avoidance and Distress Scale; IPAQ, International Physical Activity Questionnaire.
FIGURE 2Difference in social distance, pain intensity and unpleasantness, disability, and negative emotion outcomes before and after intervention. (A) Difference in social distance outcomes in the overall CLBP group before and after intervention. (B) Difference in social distance outcomes in the moderate CLBP group before and after intervention. (C) Difference in social distance outcomes in the mild CLBP group before and after intervention. (D) Difference in pain intensity and unpleasantness outcomes in the overall CLBP group before and after intervention. (E) Difference in pain intensity and unpleasantness outcomes in the moderate CLBP group before and after intervention. (F) Difference in pain intensity and unpleasantness outcomes in the mild CLBP group before and after intervention. (G) Difference in disability outcomes in the overall CLBP group before and after intervention. (H) Difference in disability outcomes in the moderate CLBP group before and after intervention. (I) Difference in disability outcomes in the mild CLBP group before and after intervention. (J) Difference in negative emotion outcomes in the overall CLBP group before and after intervention. (K) Difference in negative emotion outcomes in the moderate CLBP group before and after intervention. (L) Difference in negative emotion outcomes in the mild CLBP group before and after intervention. CD1, The comfortable distance when the subject is approached by the experimenter of the same gender; CD2, The comfortable distance when the subject is approached by the experimenter of the opposite gender; CD3, The comfortable distance when the subject walks toward the experimenter of the same gender; CD4, The comfortable distance when the subject walks toward the experimenter of the opposite gender; UD1, The uncomfortable distance when the subject is approached by the experimenter of the same gender; UD2, The uncomfortable distance when the subject is approached by the experimenter of the opposite gender; UD3, The uncomfortable distance when the subject walks toward the experimenter of the same gender; UD4, The uncomfortable distance when the subject walks toward the experimenter of the opposite gender. NRSmax, the maximum pain intensity during the last 3 days; NRSavg, the average pain intensity during the last 3 days; NRSrest, the pain intensity at rest during the last 3 days; NRSnow, the pain intensity at the moment during the last 3 days; NRSunavg, the average unpleasantness of pain during the last 3 days; NRSunnow, the unpleasantness of pain at the moment during the last 3 days; RMDQ, Roland-Morris Questionnaire; SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depression Scale.
Social distance outcomes after 8-week exercise intervention.
| Group, mean ( |
| ||||
|
| |||||
| Overall ( | Moderate ( | Mild ( | Between-group difference (95% CI) | ||
| Pre-intervention | 74.63 (31.02) | 74.83 (26.13) | 74.46 (35.35) | 0.38 (–23.82, 24.58) | 0.770 |
| Post-pre intervention | –21.08 (31.43) | –24.89 (19.19) | –17.98 (39.08) | –6.91 (–31.28, 17.47) | 0.020 |
| Pre-intervention | 86.56 (30.14) | 89.34 (28.64) | 82.29 (32.05) | 5.05 (–18.38, 28.48) | 0.560 |
| Post-pre intervention | –20.15 (27.18) | –27.08 (21.30) | –14.52 (30.65) | –12.55 (–33.17, 8.06) | 0.054 |
| Pre-intervention | 48.83 (22.28) | 47.87 (19.58) | 49.62 (24.87) | –1.75 (–19.12, 15.63) | 0.838 |
| Post-pre intervention | –14.84 (18.89) | –16.07 (14.26) | –13.85 (22.38) | –2.23 (–16.93, 12.48) | 0.161 |
| Pre-intervention | 57.22 (24.62) | 55.64 (21.45) | 58.50 (27.55) | –2.86 (–22.03, 16.31) | 0.762 |
| Post-pre intervention | –17.69 (21.16) | –19.47 (14.18) | –16.25 (25.88) | –3.23 (–19.69, 13.23) | 0.125 |
| Pre-intervention | 69.49 (25.26) | 75.21 (24.06) | 64.84 (26.02) | 10.36 (–8.92, 29.65) | 0.220 |
| Post-pre intervention | –6.96 (23.64) | –16.63 (20.67) | 0.90 (23.55) | –17.53 (–34.62, –0.43) | 0.045 |
| Pre-intervention | 76.85 (24.95) | 80.50 (22.50) | 73.87 (27.14) | 6.63 (–12.66, 25.92) | 0.487 |
| Post-pre intervention | –14.10 (23.61) | –19.97 (19.81) | –9.33 (25.93) | –10.64 (–28.58, 7.29) | 0.066 |
| Pre-intervention | 42.92 (18.53) | 45.32 (18.10) | 40.98 (19.24) | 4.34 (–10.02, 18.70) | 0.540 |
| Post-pre intervention | –7.80 (14.32) | –13.74 (10.80) | –2.97 (15.31) | –10.77 (–21.11, 0.44) | 0.042 |
| Pre-intervention | 47.75 (19.01) | 48.00 (17.98) | 47.55 (20.39) | 0.45 (–14.38, 15.27) | 0.951 |
| Post-pre intervention | –10.63 (16.55) | –15.90 (12.80) | –6.34 (18.34) | –9.56 (–21.90, 2.79) | 0.124 |
|
| |||||
| Pre-intervention | 5.24 (1.64) | 6.08 (1.44) | 4.56 (1.50) | 1.51 (0.38, 2.65) | 0.011 |
| Post-pre intervention | –2.28 (2.09) | –2.46 (1.94) | –2.12 (2.25) | –0.34 (–1.96, 1.29) | 0.372 |
|
| |||||
| Pre-intervention | 3.34 (1.47) | 4.62 (0.65) | 2.31 (1.08) | 2.30 (1.60, 3.00) | <0.001 |
| Post-pre intervention | –1.72 (1.44) | –2.31 (1.44) | –1.25 (1.29) | –1.06 (–2.10, –0.02) | 0.051 |
|
| |||||
| Pre-intervention | 2.03 (1.94) | 3.38 (1.94) | 0.94 (1.06) | 2.45 (1.29, 3.61) | 0.001 |
| Post-pre intervention | –1.21 (1.76) | –2.00 (1.96) | –0.56 (1.32) | –1.44 (–2.69, –0.19) | 0.047 |
|
| |||||
| Pre-intervention | 1.90 (1.86) | 2.54 (2.30) | 1.38 (1.26) | 1.16 (–0.21, 2.54) | 0.160 |
| Post-pre intervention | –1.07 (1.31) | –1.15 (1.46) | –1.00 (1.21) | –0.15 (–1.17, 0.86) | 0.789 |
|
| |||||
| Pre-intervention | 2.97 (2.26) | 3.85 (2.38) | 2.25 (1.95) | 1.60 (–0.05, 3.24) | 0.057 |
| Post-pre intervention | –2.24 (2.29) | –3.15 (2.34) | –1.50 (2.03) | –1.65 (–3.32, 0.01) | 0.052 |
|
| |||||
| Pre-intervention | 1.79 (1.86) | 2.23 (2.05) | 1.44 (1.67) | 0.79 (–0.62, 2.21) | 0.326 |
| Post-pre intervention | –1.24 (1.57) | –1.46 (1.51) | –1.06 (1.65) | –0.40 (–1.61, 0.81) | 0.418 |
|
| |||||
| Pre-intervention | 12.00 (5.54) | 13.15 (4.34) | 11.06 (6.34) | 2.09 (–2.15, 6.34) | 0.291 |
| Post-pre intervention | –5.79 (5.92) | –5.85 (5.73) | –5.75 (6.27) | –0.10 (–4.72, 4.53) | 0.966 |
|
| |||||
| Pre-intervention | 41.48 (8.44) | 42.54 (9.36) | 40.63 (7.82) | 1.91 (–4.63, 8.46) | 0.553 |
| Post-pre intervention | –9.48 (8.47) | –10.23 (8.19) | –8.87 (8.91) | –1.36 (–7.94, 5.23) | 0.676 |
|
| |||||
| Pre-intervention | 38.03 (9.32) | 40.31 (9.37) | 36.19 (9.16) | 4.12 (–2.97, 11.21) | 0.186 |
| Post-pre intervention | –8.17 (9.18) | –10.69 (8.42) | –6.12 (9.52) | –4.57 (–11.50, 2.37) | 0.091 |
CD1, The comfortable distance when the subject is approached by the experimenter of the same gender; CD2, The comfortable distance when the subject is approached by the experimenter of the opposite gender; CD3, The comfortable distance when the subject walks toward the experimenter of the same gender; CD4, The comfortable distance when the subject walks toward the experimenter of the opposite gender; UD1, The uncomfortable distance when the subject is approached by the experimenter of the same gender; UD2, The uncomfortable distance when the subject is approached by the experimenter of the opposite gender; UD3, The uncomfortable distance when the subject walks toward the experimenter of the same gender; UD4, The uncomfortable distance when the subject walks toward the experimenter of the opposite gender. NRSmax, the maximum pain intensity during the last 3 days; NRSavg, the average pain intensity during the last 3 days; NRSrest, the pain intensity at rest during the last 3 days; NRSnow, the pain intensity at the moment during the last 3 days; NRSunavg, the average unpleasantness of pain during the last 3 days; NRSunnow, the unpleasantness of pain at the moment during the last 3 days. RMDQ, Roland-Morris Questionnaire; SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depression Scale. *p < 0.05; **p < 0.01.